Concepedia
Statistics
Publications
7
Citations
415
H-Index
Active since
2019
Affiliations
Cornell University(Current)
Weill Cornell Medicine
Indiana University Bloomington
Rockefeller University
Howard Hughes Medical Institute
Brett Ransegnola is an author at Cornell University specializing in life sciences, microbiology, and infectious diseases.
Publications per year
2019–2024
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID-19 Patients
Larry L. Luchsinger, Brett Ransegnola, Daniel Jin et al. · Journal of Clinical Microbiology · 2020 · 178 citations · Full text
Veterinary Medicine, Immunology, Infectious Diseases +17
Serological Assays Estimate Highly Variable SARS-CoV-2 Neutralizing Antibody Activity in Recovered COVID19 Patients
Larry L. Luchsinger, Brett Ransegnola, Daniel Jin et al. · medRxiv · 2020 · 65 citations · Full text
Veterinary Medicine, Immunology, Infectious Diseases +13
Spheroplast-Mediated Carbapenem Tolerance in Gram-Negative Pathogens
Trevor Cross, Brett Ransegnola, Jung‐Ho Shin et al. · Antimicrobial Agents and Chemotherapy · 2019 · 61 citations · Full text
Life Sciences, Infectious Diseases, Microbiology +16
A multifaceted cellular damage repair and prevention pathway promotes high-level tolerance to β-lactam antibiotics
Jung‐Ho Shin, Donghui Choe, Brett Ransegnola et al. · EMBO Reports · 2021 · 42 citations · Full text
Life Sciences, Microbiology, Molecular Biology +16
Lytic transglycosylases RlpA and MltC assist in <i>Vibrio cholerae</i> daughter cell separation
Anna I. Weaver, Valeria Jiménez‐Ruiz, Srikar Tallavajhala et al. · Molecular Microbiology · 2019 · 37 citations · Full text
Life Sciences, Biology, Microbiology +16
1–5 of 7